In March 2025, the company announced new strategies for just a immediate-to-shopper supplying of its Wegovy weight loss drug. The company founded a different pharmacy, referred to as NovoCare, which might charge consumers $499 each month for entry to the drug, fewer than half the cost of the drug by way of other pharmaceutical distribution networks